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Abstract 
Background: SPTC is a mix of four herbal components (Salvia officinalis, Panax ginseng, Trigonella foenum-graeceum, 
and Cinnamomum zeylanicum) which might be prevented the development of AGE rich diet-induced diabetic 
complication and liver injury through activated the nuclear factor erythroid-2-related-factor-2 (Nrf2) pathway. Nrf2, 
as a master regulator of antioxidant response elements by activating cytoprotective genes expression, is decreased 
oxidative stress that associated with hyperglycemia and increases insulin sensitivity. the aim of this study was to assess 
whether the combination therapy of SPTC along with exercise or metformin moderate oxidative stress related liver 
injurie with more favorable effects in the treatment of AGE rich diet-induced type 2 diabetic mice.
Methods: We induced diabetes in C57BL/6 mice by AGE using a diet supplementation and limitation of physical 
activity. After 16 weeks of intervention, AGE fed mice were compared to control mice. Diabetic mice were assigned 
into seven experimental groups (each group; n = 5): diabetic mice, diabetic mice treated with SPTC (130 mg/kg), 
diabetic mice treated with Salvia Officinalis (65 mg/kg), diabetic mice treated with metformin (300 mg/kg), diabetic 
mice with endurance exercise training, diabetic mice treated with SPTC + metformin (130/300 mg/kg), diabetic mice 
treated with SPTC + exercise training.
© The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which 
permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the 
original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or 
other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line 
to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory 
regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this 
licence, visit http://creat iveco mmons .org/licen ses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creat iveco 
mmons .org/publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Open Access
*Correspondence:  mh.nasr-esfahani@royaninstitute.org; kamranghaedi@sci.
ui.ac.ir; kamranghaedi@yahoo.com
1 Department of Cell and Molecular Biology and Microbiology, Faculty 
of Biological Science and Technology, University of Isfahan, Hezar Jerib 
Avenue, Azadi Sq., Isfahan 81746-73441, Iran
3 Department of Animal Biotechnology, Cell Science Research Center, 
Royan Institute for Biotechnology, ACECR, Royan Street, Salman Street, 
Isfahan 816513-1378, Iran
Full list of author information is available at the end of the article
Page 2 of 14Rahimi et al. Nutr Metab (Lond)           (2021) 18:14 
Introduction
One of the most complex prevalent disorders all over the 
world is Type 2 diabetes mellitus (T2DM) that is rap-
idly growing globally. T2DM has been connected with 
unhealthy dietary habits, including high carbohydrate 
and advanced glycation end products (AGE) rich meals 
and sedimentary life-style, and obesity in recent years 
[1–3]. Heterogeneous pathomolecular cause of diabetes 
is associated with modulation in several signaling path-
ways, in which most important of them is stress oxida-
tive. In general, T2DM is characterized by hyperglycemia 
and hyperinsulinemia that could lead to pro-stress oxida-
tive conditions which could be enhanced levels of reac-
tive oxygen species (ROS), inflammatory factors, and 
reduction of the antioxidant defenses that cause tissue 
injury and long term complications of T2DM [4].
The body is equipped with several defense mecha-
nisms against oxidative stress and via this mechanism 
can return to normal conditions. Nrf2-Keap1 signaling 
pathway is one of the well-known of these molecular 
mechanisms. Nrf2 has a cytoprotective role in response 
to oxidative stress [5, 6] as well as in insulin sensitivity, 
glucose metabolism, mitochondrial bioenergetics, lipid 
metabolism, inflammation alleviation, drug metabo-
lism [7]. Nrf2 signaling is triggered by detachment from 
Keap1 (a protein-rich in cysteine and Nrf2 inhibitor), 
and translocation of Nrf2 to the nucleus. Subsequently, 
Nrf2 targets the expression of downstream genes with 
antioxidant response elements (ARE) in their regulatory 
regions Such as Gpx1, HO1, Nqo1, and Txn [8, 9]. Path-
way hierarchy, compounds inducers of ARE related genes 
expression could independently alter Nrf2-Keap1 struc-
ture such as reactive cysteine (Cys) residues in Keap1. 
Depletion of Nrf2-Keap1 signaling pathway has been 
closely correlated with T2DM complications like diabetic 
retinopathy and cardiomyopathy and pancreatic β-cell 
damage. Actually, Keap1–Nrf2 system activation might 
be attenuated the damage by stress oxidative and inflam-
mation in diabetes. It was previously reported that Nrf2-
inducers could be suppressed stress oxidative markers 
and subsequently related damage [10].
Nowadays, herbal medicine and physical activity are 
used as a natural approach to increase antioxidant and 
anti-inflammatory abilities to combat the micro- and 
macrovascular complications of diabetes [1]. In tradi-
tional oriental medicine, herbal extracts have been exten-
sively used as effective medication against T2DM for a 
long time [11]. The herbal mixture of SPTC that we used 
in the present study consists of leaves and seeds aqueous 
extract of four plants include Salvia officinalis, Panax 
ginseng, Trigonella foenum-graeceum, and Cinnamomum 
zeylanicum with already identified antioxidant potential. 
Favorable antioxidant impact of SPTC is due to its flavo-
noids and polyphenolic components such as ginsenoside, 
salvianolic acid A, carnosic acid. Intense studies have 
indicated that treatment with antioxidant reagents might 
be used as an effective approach in preventing ROS medi-
ated pancreas damage. Indeed, antioxidant therapy could 
improve secretion of insulin from pancreatic islets and 
involve in alleviating pancreatic b-cell damage in diabetic 
individuals [10]. Therefore, SPTC might be accounted for 
a reduction of T2DM complications through blocking of 
stress oxidative pathways.
An alternative factor for improving cell metabolic 
responses and insulin sensitivity is a regular exercise that 
is prescribed for relieving T2DM. Physical activity is a 
well-evidenced feasible approach for maintaining meta-
bolic homeostasis and attenuate complications of diabe-
tes [12]. A variety of studies have supported the beneficial 
effects of exercise, which is mediated through activation 
of the Nrf2 pathway and increasing endogenous antioxi-
dant defense [13]. Exercise affects through Nrf2 signaling 
with different mechanisms including increasing ROS lead 
to oxidation and modification of keap1 cysteine residues 
[14]. However, moderate exercise-induced ROS could 
suppress the oxidative damage by increasing adaptive 
responses of the body and improving antioxidant capac-
ity in tissues. [15]. This adaptive activation have more 
protective effects when accompanied by antioxidants 
treatment [16]. Generally, exercise in combination with 
antioxidants or Nrf2 activator supplementation has more 
significant effects on oxidative stress situation in the liver 
[14].
According to evidence, T2DM is an increasing global 
pandemic and the age of T2DM outbreak continues to 
decrease [17]. Hence, it is of great significance to explore 
Results: SPTC + exercise and SPTC + metformin reduced diabetic complications like gain weight, water and calo-
rie intake, blood glucose, insulin, and GLUT4 content more efficiently than each treatment. These combinations 
improved oxidative stress hemostasis by activating the Nrf2 signaling pathway and attenuating keap1 protein more 
significantly.
Conclusion: Eventually, combined treatment of SPTC with exercise or metformin as a novel approach had more 
beneficial effects to prevent the development of diabetes and oxidative stress associated with hyperglycemia.
Keywords: AGE rich diet, Diabetes, Exercise, Herbal drug, Nrf2-keep pathway, Stress oxidative
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more efficient therapeutic approach to decrease and delay 
the development of T2DM condition. One of the first 
anti-diabetic medication is metformin which has been 
used as a basic pharmacological therapy in diabetes treat-
ment. However, evidence has proposed that metformin 
therapy is associated with gastrointestinal tract adverse 
effects and metformin might be suffered from these side 
effects. [18]. On the other hand, long term of metformin 
therapy may lead to prevalence of other diseases like 
peripheral neuropathy. Accordingly, these aspects high-
light a need for herbal drug therapy in diabetic patients. 
Considering the relation between the stress oxidative, 
development of diabetes complications, the role of SPTC 
components, and endurance exercise in improving anti-
oxidant and anti-inflammatory abilities, we hypothesized 
that utilizing the variance capacity of Nrf2-keap1 com-
plex through exercise and medication with SPTC, might 
be more efficient to stimulate Nrf2 detachment of keap1 
and regulate diabetic related oxidative stress. As both 
diet type and calorie intake are prominent environmental 
factors in the pathogenesis and development of T2DM, 
in the present study we used advanced glycation end 
products (AGE) rich diet to induce diabetic mice. Since 
AGE have an important role in liver fibrosis develop-
ment [20] and liver dysfunction is one of the principal 
complication of T2DM [21], we aimed to assess to exam-
ine aforementioned pathways in the liver tissue. In this 
study we examine the role of combination therapy with 
SPTC + exercise and SPTC + metformin compared with 
each treatment alone to improve T2DM complication 
and stress oxidative markers include antioxidant capac-
ity and Nrf2-keap1 signaling pathways in AGE rich diet-
induced type 2 diabetic mice. Totally, our results showed 
that SPTC in combination with exercise or metformin 




All experiments were conducted following the guidelines 
of the committee of the Royan Institute (IR. ACECR.
ROYAN.REC1398.44). Mice were acclimatized to the 
Royan animal housing condition for two weeks.
Experimental animal and treatments
Four-week-old male C57BL/6 mice were procured 
from Royan Institute for Biotechnology (Isfahan, Iran) 
and were housed in a temperature-controlled facility 
(24 ± 3 °C and humidity of 65% ± 5), under a 12 h light–
dark cycle. They were held ad  libitum to access water 
and foods throughout the study. After adaptation, mice 
with an approximate weight of 14 ± 2  g, were randomly 
divided into two groups of control (Ctrl) and diabetic 
mice (DM) that respectively fed with normal diet and 
(AGE)-rich diet (Abedpoor et  al., Unpublished data) 
which were obtained from Royan Institute for Biotech-
nology, for 16  weeks. After ensuring the emergence of 
DM, the diabetic group was divided into seven groups 
randomly (n = 5), as follows: (1) diabetic mice (DM 
group), (2) diabetic mice treated with SPTC (130  mg/
kg, DM/SPTC group), (3) diabetic mice treated with 
Salvia Officinalis (65 mg/kg, DM/Sal), (4) diabetic mice 
treated with metformin (300  mg/kg,  DM/Met), (5) dia-
betic mice with endurance exercise training (DM/EX), (6) 
diabetic mice treated with SPTC + metformin (130  mg/
kg + 300  mg/kg respectively, DM/SPTC + Met), (7) dia-
betic mice treated with SPTC + exercise training (DM/
SPTC + EX).
SPTC (Salvia officinalis 145 mg, Panax ginseng 145 mg, 
Trigonella foenum-graeceum 65 mg, and 25 mg Cinnamo-
mum zeylanicum) and Salvia were provided as a dried 
powder. All chemical and herbal drugs were adminis-
tered as a gavage supplement, five times per week (day 1 
up to 5/each week) for 8 weeks.
During the experiment period, body weight was meas-
ured weekly. In addition, calorie intake, and water drink-
ing were monitored daily. At the end of experiment, 
mice were sacrificed under xylazine and ketamine anes-
thesia. Blood and tissue samples were collected for fur-
ther tests. In the Fig. 1 we designed the flowchart of our 
experiments.
Biochemical analyses of plasma glucose, insulin levels, 
blood ROS, and Total antioxidant capacity
The plasma level of insulin was determined by Ultra-
Sensitive Mouse Insulin ELISA Kit (Crystal Chem, US) 
according to the protocol. Glucose tolerance test (GTT) 
and fasting blood sugar (FBS) were measured using an 
Alpha TRAK glucometer and its standard strips (Zoe-
tis, US) as described elsewhere. The blood ROS activ-
ity was measured with the OxiSelect Intracellular ROS 
Assay Kit (Cell Biolabs, USA) according to the manufac-
turer’s instruction. Total antioxidant capacity of blood 
was measured by OxiSelect Total Antioxidant Capacity 
(TAC) Assay Kit (Cell Biolabs, USA).
Exercise training protocol
Endurance exercise was applied as a type of moderate-
high intensity exercise on a motorized treadmill with a 0° 
incline during 8 weeks (5 days/week). At first, mice were 
acclimated to treadmill exercise for two weeks, and after 
that speed and duration of treadmill training were gradu-
ally increased at a rate of 3 m/min from 10 to 25 m/min 
in the final session for 45 min (~ 70%  VO2 max).
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Quantitative real‑time PCR (qRT‑PCR)
Total RNA was isolated from the liver using TRIzol rea-
gent (Thermo Scientific, USA). To remove contaminat-
ing genomic DNA, samples were treated with DNaseI 
(TaKaRa, Japan). mRNA was reverse transcribed with 
1 μg of total RNA using the cDNA synthesis kit accord-
ing to the manufacturer’s instruction (TaKaRa). qRT-
PCR was performed with CYBR green (TaKaRa, Japan) 
on an Applied Biosystems real-time PCR thermal cycler 
(Thermo Fisher Scientific, Waltham, MA, USA). Evalu-
ation of gene expression was carried out according to 
the  2−ΔΔct method. Accordingly, relative quantification 
was calculated according to 18  s rRNA as an internal 
control (Housekeeping). Primers were ordered from 
micro-gene (Korea), and their sequences are shown in 
Table 1.
Fig. 1 Designed a representation of flowchart. As shown, acclimation was performed for two weeks. mice with an approximate weight of 14 ± 2 g, 
were randomly divided into two groups of control (Ctrl) and diabetic mice (DM) that respectively fed with normal diet and (AGE)-rich diet for 
16 weeks. After ensuring the emergence of DM, the diabetic group was divided into seven groups randomly (n = 5), as follows: 1. Diabetic mice 
(DM group), 2. Diabetic mice treated with SPTC (130 mg/kg, DM/SPTC group), 3. Diabetic mice treated with Salvia Officinalis (65 mg/kg, DM/
Sal), 4. Diabetic mice treated with metformin (300 mg/kg, DM/Met), 5. Diabetic mice with endurance exercise training (DM/EX), 6.Diabetic mice 
treated with SPTC + metformin (130 mg/kg + 300 mg/kg respectively, DM/SPTC + Met) 7. Diabetic mice treated with SPTC + exercise training (DM/
SPTC + EX)
Table 1 Primer list
Gene Forward primer (5′‑3′) Reverse primer (5′–3′) Annealing 
temperature 
(°C)
Gpx1 TGA GAA GTG CGA AGT GAA TGGTG TCT CAA AGT TCC AGG CAA TGTCG 62
Txn CTC CCC GCA ACA GCC AAA GCA GTC ATC CAC ATC CAC TTCAA 62
Nqo1 GCC AAT CAG CGT TCG GTA AGT TCA TAG CAT AGA GGT CAGA 62
HO1 GGC TGT GAA CTC TGT CTC ATA CCC ACC ATC ACA CCC TG 56
18 s rRNA CGG ACA CGG ACA GGA TTG TCG CTC CAC CAA CTA AGA AC 59
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Western blot analysis
Tissue proteins were extracted using TRI reagent, accord-
ing to the manufacturer protocol. Proteins were resolved 
by SDS-PAGE (10%) and transferred to PVDF mem-
branes (Bio-Rad, USA). Membranes were blocked with 
different blocking buffer containing 10% skim milk (Mil-
lipore, USA), and 5% TBST. Then, they were respectively 
incubated with primary antibodies for 1.5  h (Anti-Nrf2 
antibody [1:1000, EP1808Y, Abcam, UK], Anti-Glucose 
Transporter GLUT4 [1:2000, ab188317, Abcam, UK], 
anti- β actin antibody (1:500, Sigma, USA), anti-Keap1 
antibody [1:1000, ab119403, Abcam, UK] and secondary 
antibodies (Goat Anti-Rabbit IgG H&L (HRP) (1:20,000, 
Santa Cruz SC-2301, HRP-conjugated goat antimouse 
IgG (1:5000, Dako, Japan P0447), for 1  h at room tem-
perature. Blots were detected by an Amersham ECL 
Advance Western Blotting Detection Kit (GE Healthcare, 
USA). Image J software (National Institutes of Health, 
Bethesda, MD, USA) was utilized for quantification of 
the intensity band.
Histological studies
Immediately after mice sacrificing, tissues were fixed 
in 10% buffered formalin and embedded in paraffin. 
Accordingly, fixed tissues were cut into slices with 5 µm 
thickness. After deparaffinization and hydration, tissue 
sections were stained with hematoxylin and eosin (H&E) 
and finally were observed under light microscopy.
ROS detection
ROS generation in mice liver was measured by using 
2′,7′-Dichlorofluorescin Diacetate (DCFDA) fluores-
cence method as previously described. Briefly, liver sam-
ples (100  mg) were homogenized in 1  mL ice-cooled 
(4  °C) 40  mM Tris–HCl buffer (pH:7.4). After diluting 
to 0.25% with the same buffer, the total homogenate of 
each sample was divided into two equal portions of 2 mL. 
Approximately 40  μL of 1.25  mM DCFDA was added 
to one portion, and the same volume of methanol was 
added to the other portion (Control). After 20 min incu-
bation of all samples in 37 °C, the conversion of DCFH to 
the fluorescent product DCF was determined at 488 nm 
excitation and 525  nm emission using BD FACSCalibur 
Flow Cytometer (Becton Dickinson, USA). The results 
were evaluated according to DCF fluorescence intensity.
Total antioxidant capacity
Total antioxidant capacity of tissue and drug sam-
ples were determined using Ferric Reducing Antioxi-
dant Power (FRAP) Assay Kit (Naxifer™- TAC Capacity 
Assay Kit, NS-15012, Iran) as described in manufacturer 
protocol.
Statistical analysis
The statistical analyses were carried out using GraphPad 
Prism 8.5 software (GraphPad Software, San Diego, CA, 
USA). The paired samples t-test was performed to eval-
uate the diabetic group compared to the control group. 
Also, One-way analysis of variance (ANOVA) was used 
to make comparisons between all treatment groups. 
All experimental results are presented as mean ± SD. p 
value < 0.05 represents significant difference between the 
samples.
Results
Diet enriched with AGE contributed to the development 
of diabetic complications
Our data clearly showed (AGE)-rich diet contributed to 
increase calorie intake and water drinking of model mice 
(Table 2). The weight gain percentile of AGE diet group 
was more than the control group (Fig. 2a). Moreover, the 
measurement of liver/body weight ratio was shown that 
Table 2 Liver/body weight ratio, Calorie intake, and water drinking amount
Values are expressed as mean ± SD
a Indicates statistically significant difference with control group at p < 0.05
b Indicates statistically significant difference with DM at p < 0.05
Groups (n = 5) Relative liver weight (g liver/g body weight 
%)
Water consumption (mL/day/mouse) Calories intake 
(Kcal/day/mouse)
Control 4.8 ± 0.06 3.65 ± 0.1 3.71 ± 1.45
DM 6 ± 0.22a 5.89 ± 0.29a 8.9 ± 0.46a
DM/Met 4.1 ± 0.12b 4.2 ± 0.3b 5.38 ± 1.33b
DM/SPTC 3.8 ± 0.19b 3.85 ± 0.26b 6.22 ± 1.2b
DM/ SPTC + Met 3 ± 0.3b 4.5 ± 0.13b 5.23 ± 1.39b
DM/Sal 3.5 ± 0.09b 4.32 ± 0.15b 4.3 ± 1.26b
DM/EX 3.9 ± 0.1b 4.85 ± 0.6b 4.99 ± 1.65b
DM/ SPTC + EX 3.1 ± 0.16b 3.98 ± 0.16b 4.21 ± 1.38b
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AGE diet causes increasing liver/body weight in DM 
model mice (Table 2).
After 16 weeks of (AGE)-rich diet consumption, mor-
phological characteristics of liver tissue are significantly 
changed (Fig.  3). As a result, (AGE)-rich diet played 
an essential role in the histopathological characteris-
tics of the liver. HE staining data from diabetic mice 
demonstrated the development of steatosis, lymphatic 
infiltration, and vacuolation of the liver (Fig. 3b, c). AGE 
diet mice also had a larger liver size compare to the nor-
mal diet mice (Fig. 3a). Despite such a clear difference in 
liver characteristics, HE staining of pancreatic and mus-
cle tissue exhibited no vital difference compared with the 
control group (Data not shown).
Fig. 2 (AGE)-rich diet exacerbates diabetic symptoms in diabetic mice rather than control mice. Control mice (Ctrl) and AGE rich diet-induced 
diabetic mice, body weight ratios and weight gain percentile (a). Measurement of plasma insulin concentration, HOMA-IR and fasting blood sugar 
(b). Glucose concentration and area under the curve glucose (c). GLUT4 protein expression in skeletal muscle (d). All values were expressed as 
mean ± SD (n = 5 per group). #p < 0.05, ##p < 0.01 indicate statistically significant difference in the diabetic mice in comparison to the control mice. 
Data were analyzed by t-tests
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Molecular and biochemical assays
Based on evidence Glucose intolerance and hyper-
insulinemia are related onsets for diabetes. Our data 
indicated that plasma insulin and glucose levels were 
elevated in mice after 16  weeks by AGE diet. Plasma 
insulin and glucose tolerance tests (AUC insulin and 
AUC glucose) were higher in mice with AGE diet com-
pared to mice with a normal diet (Fig.  2b, c). Subse-
quently, we calculated insulin resistance (HOMA-IR). 
As depicted, the HOMA-IR index for (AGE)-rich diet 
mice was significantly amplified (Fig.  2b). Mice on 
(AGE)-rich diet displayed significantly higher insulin 
resistance than mice on normal diet.
Insulin resistance triggers Glut4 pathway impairment 
in skeletal muscle and, finally, glucose uptake defi-
ciency. Determination of GLUT4 expression revealed 
that this protein level was reduced in mice on (AGE)-
rich diet (Fig. 2d).
Fig. 3 (AGE)-rich diet induces liver damage in diabetic mice rather than control mice. Liver morphology of control and diabetic mice (a). H & E 
staining of liver tissue (b). Semi-quantitative evaluation of steatosis, lymphatic infiltration, and vacuolation in liver tissues (c). Values were expressed 
as mean ± SD (n = 5 per group). ##p < 0.01 indicates a statistically significant difference in diabetic mice in comparison to the control mice. Data 
were analyzed by t-tests. Liver damage were scored by a pathologist after observing the samples of H & E staining
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(AGE)‑rich diet increased oxidative stress in liver
To investigate whether (AGE)-rich diet contributes to 
making oxidative stress, we analyzed some parameters 
for oxidative stress in diabetic mice. The data showed 
that AGE diet raised the amount of ROS in diabetic mice 
compared to control mice. In the liver, gated cells with 
DCF (a marker of ROS) increased from 25.03% in the 
control group to 63.65% in the AGE diet group. As well, 
AGE diet increased ROS level of blood in diabetic group 
compared to control (Fig. 4a).
Consistently, the total antioxidant capacity of liver 
and blood declined in the AGE diet group compared to 
the control (Fig.  4b). Consequently, we also determined 
Keap1 and Nrf2 protein levels and related antioxidant 
genes expression as one of the main signaling pathway 
involved in oxidative stress regulation. AGE diet resulted 
in enhancement of the keap1 protein levels whereas, it 
might be reduced Nrf2 protein levels and downstream 
antioxidant genes Gpx1, Nqo1, HO1, and Txn at the level 
of transcription in (Fig. 4c, d). (AGE)-rich diet emerged 
Fig. 4 (AGE)-rich diet impaired by the endogenous redox system in liver. Liver ROS production was measured using DCF fluorescence method, 
blood ROS level was determined by ELISA Kit (a). Total antioxidant capacity of liver and blood (b). Gpx1, HO1, Nqo1, and Txn expression were 
measured using qPCR and normalized to 18 s rRNA (c). Nrf2 and Keap1 proteins expression in liver (d). Values were expressed as mean ± SD (n = 5 
per group). #p < 0.05 indicates a statistically significant difference in diabetic mice in comparison to the control mice. Data were analyzed by t-tests
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to disturb the balance between ROS generation and anti-
oxidant defense system.
SPTC, as well as exercise, diminished diabetes 
complications
After inducing diabetes via (AGE)-rich diet, mice were 
treated with either SPTC or exercise and a compound 
type of both interventions. The main body portion of 
SPTC was Salvia extract. Therefore, one group of mice 
was treated with Salvia extract (DM/Salvia). As posi-
tive controls, metformin-treated group, and metformin 
combination with SPTC were also implemented to assess 
whether SPTC could able to alleviate the diabetes symp-
toms or not. Despite the reduction of diabetes compli-
cations in all groups relative to the control (no received 
SPTC, metformin or exercise, and Salvia, Table  2). 
Besides, liver/body weight ratio in DM mice reduced 
partly after 8 weeks of treatment with SPTC, metformin, 
Salvia, and endurance exercise compared to the dia-
betic group. Furthermore, the simultaneous treatment 
of SPTC plus exercise and SPTC plus metformin caused 
a decrease in the ratio of liver/body weight compared to 
the diabetic group (Table 2).
Glucose test tolerance in SPTC, endurance exercise 
(Ex), and metformin (Met) groups significantly reduced 
compared with diabetic group (DM). Notably, we found 
that the SPTC group compared to other groups had more 
effective and predominately decreased the Blood glucose 
levels (Fig. 5b).
Moreover, plasma insulin and FBS were significantly 
decreased after applying all treatment. However, FBS in 
SPTC plus exercise (SPTC + EX) and SPTC plus met-
formin (SPTC-Met) groups declined compared to the 
sole treated group (Fig. 5a). We also calculated HOMA-
IR in all groups. It was lower in all treatment groups, and 
then this reduction was more in combination groups of 
SPTC plus exercise (SPTC + EX) and SPTC plus met-
formin (SPTC + Met) than groups of SPTC, metformin 
(Met), Salvia (Sal), and endurance exercise (EX) (Fig. 5a).
The protein expression levels of GLUT4 were measured 
in skeletal muscle of all treatment groups. The level of 
GLUT4 was enhanced in all treatment groups compared 
to the diabetic group. Additionally, in SPTC plus exercise 
(SPTC + EX) and SPTC plus metformin (SPTC + Met) 
were significantly increased than SPTC, metformin 
(Met), Salvia (Sal), and endurance exercise (EX) (Fig. 5c).
Attenuation of oxidative stress was significant in SPTC 
plus exercise (SPTC + EX), and SPTC plus metformin 
(SPTC + Met)‑treated groups.
SPTC, endurance exercise, and metformin treatment 
amplified the total antioxidant capacity of the liver and 
blood. Of important antioxidant capacity of SPTC was 
more than metformin (Met) and it was supposed to be 
mainly due to the constituents of Salvia extract (Addi-
tional file  1: Fig. S1). Nevertheless, SPTC plus exercise 
(SPTC + EX) and SPTC plus metformin (SPTC + Met) 
restored total antioxidant capacity more than those 
treatments alone (Fig.  6a). We observed that combina-
tory treatments increased the abundance of Nrf2 and 
decreased Keap1 proteins (Fig.  6c). Consistently, SPTC 
plus exercise (SPTC + EX) and SPTC plus metformin 
(SPTC + Met) groups indicated a more increased in Nrf2 
levels and antioxidant gene expression compared to each 
treatment alone. Moreover, transcript levels of liver anti-
oxidant genes, including Gpx1, Nqo1, HO1, and Txn, 
were significantly increased in groups of SPTC, exercise 
(EX), metformin (Met), and Salvia (Sal), whereas they 
were higher in SPTC plus exercise (SPTC + EX) and 
SPTC plus metformin (SPTC + Met) (Fig. 6b).
Discussion
The present study indicated more pronounced effects 
of the combination of SPTC with exercise or metformin 
on diabetic complications and oxidative stress in dia-
betic mice which induced with (AGE)-rich diet com-
pared to each treatment alone. Animal model (mouse) 
was employed in this study to create model of human 
diabetes mellitus with (AGE)-rich diet and then treated 
with SPTC plus exercise or metformin. After testing our 
hypothesis and assisting all aspects of our treatment 
effects in animal modeling, it might be used in human 
trials. The primary results of the study were favora-
ble in reducing diabetes complications in mouse model 
and emerging evidence propose promising therapeutic 
methods. Further research is needed on this potential 
approaches. Hence, we could obtain scientifically valid 
research and expand our study to humans in the future.
In this study, high oxidative stress markers were 
observed after consumption of (AGE)-rich diet in 
C57BL/6 mice liver and blood. These results were in good 
agreement with the previous studies that exhibited the 
role of AGE and RAGE in the progression of metabolic 
(See figure on next page.)
Fig. 5 Improvement of diabetic complications of AGE rich diet-induced diabetic mice with different treatment groups. Measurement of plasma 
insulin concentration, HOMA-IR and fasting blood sugar (a). Glucose concentration and area under the curve glucose (b). GLUT4 protein expression 
in skeletal muscle (c). All values were expressed as mean ± SD (n = 5 per group). Data were analyzed by one-way analysis of variance (ANOVA) and 
Tukey’s post hoc test
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syndrome like DM by activation of oxidative stress and 
inflammatory pathways [22, 23]. AGE could be led to 
ROS production by interacting with its ligand-receptor 
RAGE and leading to NADPH oxidase activation [24]. 
It has been explored that in type 2 diabetes, AGE-RAGE 
signaling inhibited SIRT1 expression and subsequently 
downregulation of Nrf2 and downstream antioxidant 
genes [25]. Dysfunction in Nrf2-keap1 signaling as an 
essential defense system against oxidative stress was 
indicated in the growing evidence which results in an 
Fig. 6 Improvement of oxidative stress condition of AGE rich diet-induced diabetic mice with different treatment groups. Total antioxidant capacity 
of liver and blood (a). Gpx1, HO1, Nqo1, and Txn mRNA expression were measured using qPCR and normalized to 18 s rRNA (b). Nrf2 and Keap1 
proteins expression in liver (c). Values were expressed as mean ± SD (n = 5 per group). Data were analyzed by one-way analysis of variance (ANOVA) 
and Tukey’s post hoc test
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imbalance between antioxidant and ROS production, 
and subsequently leads to high blood glucose associated 
with DM [26]. This is evident that Keap1–Nrf2 signal-
ing pathways notably control insulin secretion and glu-
cose consumption in many tissues and also have a role in 
regulation of lipid metabolism. Therefore, activation of 
Keap1–Nrf2 pathways make to maintenance of glucose 
metabolism and homeostasis. In addition, Nrf2-ARE 
signaling have a protective role against ROS and inflam-
mation related pancreatic β-cell damage, as a marked 
pathological impairment in D2M [10].
In the liver, there is a relevant pathway of Nrf2 
restricted gluconeogenesis-related gene expression which 
plays a role in insulin sensitivity, maintenance of normal 
level of blood glucose and obesity prevention [27]. More-
over, some reports claimed that treatment with Nrf2 
inducers like SFN lead to inhibition of the hepatic dete-
rioration through Nrf2/ARE signaling pathways activa-
tion in some liver disease [10]. In the present manuscript 
we have tried to figure out an interconnection with acti-
vation of Nrf2-keap1 signaling pathway as a multifacto-
rial process and modulation of oxidative stress associates 
with diabetes.
Additionally, we investigated significant depletion of 
blood glucose and insulin levels, insulin resistance, and 
GLUT4 protein level was increased in after treatment 
with SPTC, endurance exercise training, metformin, 
and combination treatment of SPTC plus exercise 
(SPTC + EX) and SPTC plus metformin (SPTC + Met). In 
general, diabetic complications decreased further in com-
bination treatment of SPTC plus exercise (SPTC + EX) 
and SPTC plus metformin (SPTC + Met) compared to 
each treatment of SPTC, exercise (EX), Salvia (Sal), and 
metformin (Met). Moreover, we found that SPTC and 
exercise (EX) might be had strong antioxidant effects on 
diabetic mice which fed (AGE)-rich diet as observed by 
elevation of Nrf2 protein level and HO1, Gpx1, Txn, and 
Nqo1 genes expression and depletion of Keap1 protein 
level in liver. Furthermore, combination treatment could 
be had the highest additive effect in the induction of anti-
oxidant capacity of the liver and blood rather than each 
treatment alone.
Antioxidant therapy as new clinical trials is promisingly 
used for medicinal purposes [28]. Currently, phenolic 
compounds like flavonoids and polyphenols which have 
natural origins and lesser side effects compared to syn-
thetic drugs are widely suggested to treat diabetic damage 
[29]. Given that, mixed therapy of antioxidant herb with 
other antidiabetic applications had more combination 
effects, we hypothesized that Nrf2 signaling antioxidant 
activator might be affected with exercise and metformin 
than each treatment alone. Our results showed that com-
bination treatment of SPTC plus exercise and SPTC plus 
metformin exerts more capable effects in diabetic injury 
and modulation of oxidative stress. Also, our findings 
indicated that these combined interventions in this study 
strongly caused more control oxidative stress by activa-
tion of the Nrf2-keap1 signaling pathway. This is possibly 
mediated by various complementary mechanisms that 
lead to Nrf2 activation and thereby induction of related 
downstream cytoprotective gene expression.
Salvia officinalis with significant bioactive composition 
have been extensively used for the treatment of type 2 
diabetes in herbal medicine [30]. Carnosic acid is one of 
the main polyphenolic diterpenes of Salvia officinalis and 
was found as an activator for Nrf2-keap1 transcriptional 
pathway. Takumi and colleagues have observed that Car-
nosic acid led to phase 2 enzymes induction by binding 
to keap1 cysteines and Nrf2 nuclear translocation [31]. 
Salvianolic acid A is another robust antioxidant com-
pounds found in herb Salvia officinalis and was reported 
to activate Akt/mTORC1 signaling which results in Nrf2 
phosphorylation [32, 33]. Ginseng, as a traditional anti-
diabetic herb was demonstrated to inhibit pro-inflam-
matory factors and promotes the Nrf2/keap1 pathway. 
Ginsenoside Rg1, the main active ingredient of Ginseng, 
by decreasing NLRP3 leads to down-regulation of ILb, 
which further restricted NF-κB activation [34]. NF-κB 
unidirectionally acts as an antagonizing factor against the 
Nrf2 through depletion of MAF protein, which interacts 
with Nrf2 [35].
As we reported, exercise training and metformin 
treatment diminished diabetic complications and 
induced Nrf2-keap1 signaling pathway. Nonetheless, 
as mentioned, their effects were more pronounced in 
combination with SPTC. It is presumable that differ-
ent mechanisms of each treatment had possibly addi-
tive effects to improve DM and reduced oxidative stress 
injury. Metformin, as a first-line antidiabetic medicine, 
was reported to induce Nrf2 gene expression along with 
BACH1 protein reduction [36]. BACH1 protein was rec-
ognized as an Nrf2 repressor by binding to Nrf2 sites and 
causes inhibition of antioxidant response element genes 
expression [37].
Exercise with increasing ROS moderately and oxida-
tion of cysteines residues of keap1, leads to the forma-
tion of disulfide bridges, alteration of the Nrf2/Keap1/
Cul3 Complex structure and Nrf2 detachment from 
keap1 [13, 14]. In response to inducing ROS forma-
tion during physical training, Nrf2 is activated through 
oxidation of the cysteine residues in Keap1 and subse-
quently Nrf2 dissociation [38]. Moreover, it has been 
reported that PGC-1α modulates the systems to toler-
ate induced ROS production in exercise. Exercise could 
be induced PGC-1α protein expression and activation. 
Therefore, PGC-1α might interact with Nrf2 and causes 
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antioxidant gene expression. This interaction and 
induction of Nrf2 related pathways are involved in dif-
ferent adaptations to long term training [39].
Besides, our finding showed that the antidiabetic 
approach combining the protective effects of SPTC is 
association with exercise training and metformin and 
have more effective in modulating oxidative stress 
associated with type 2 diabetes. This study generally 
reported that SPTC plus exercise and SPTC plus met-
formin dramatically reversed AGE induced diabetic 
changes and decreased oxidative stress injury more 
than each treatment alone. Moreover, all treatments 
of SPTC, exercise, metformin, Salvia and their com-
binations reduced blood glucose and insulin levels, 
insulin resistance and increased GLUT4 protein level. 
Moreover, all treatment amplified Nrf2 protein levels 
and its antioxidant gene expression of HO1, Nqo1, Gpx, 
and Txn and declined Keap1 protein level in diabetic 
mice liver. These favorable effects were more remark-
able in combination treatment. Consequently, we sug-
gested that combination therapy of SPTC plus exercise 
(SPTC + EX) or metformin (SPTC + Met) could serve 
as a potential intervention approach through activating 
the Nrf2-keap1 pathway and alleviating oxidative stress 
associated with diabetes mellitus. We hope that future 
studies will obtain further experimental data to support 
our results.
Conclusion
Our data demonstrated beneficial effects of SPTC sup-
plementation in combination with exercise (SPTC + EX) 
or metformin (SPTC + Met) in (diabetic mice than 
each treatment alone, suggesting that SPTC + EX and 
SPTC + Met could be an accessible and therapeutic 
approach related to lifestyle in diabetic individuals.
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